  The Critical Assessment of Genome Interpretation (CAGI) aims to advance the
state of the art for computational prediction of genetic variant impact,
particularly those relevant to disease. The five complete editions of the CAGI
community experiment comprised 50 challenges, in which participants made blind
predictions of phenotypes from genetic data, and these were evaluated by
independent assessors. Overall, results show that while current methods are
imperfect, they have major utility for research and clinical applications.
Missense variant interpretation methods are able to estimate biochemical
effects with increasing accuracy. Performance is particularly strong for
clinical pathogenic variants, including some difficult-to-diagnose cases, and
extends to interpretation of cancer-related variants. Assessment of methods for
regulatory variants and complex trait disease risk is less definitive, and
indicates performance potentially suitable for auxiliary use in the clinic.
Emerging methods and increasingly large, robust datasets for training and
assessment promise further progress ahead.
